Navigation Links
First of Its Kind Data Show: Immediate Treatment of Early MS,Patients with Betaseron Significantly Delayed Permanent Disability

Risk to confirmed EDSS progression reduced by 40 percent compared to delayed treatment

BOSTON, May 01, 2007 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals announced today new data, which show that immediate initiation(1) of Betaseron(R) (interferon beta-1b) treatment in patients with a first event suggestive of multiple sclerosis (MS) can significantly reduce the risk of permanent neurological impairment as measured by the Expanded Disability Status Scale (EDSS) by 40 percent(2) over three years compared to delayed treatment(3). These findings from the BENEFIT (BEtaseron in Newly Emerging multiple sclerosis For Initial Treatment) studies(4) were presented today at the American Academy of Neurology's 59th Annual Meeting in Boston, Massachusetts.

"Some patients have already developed significant neurological damage when they first present with signs of MS, which can lead to accumulated disability later in life. The BENEFIT results clearly show that immediate treatment with Betaseron initiated after the first clinical event can significantly reduce that damage, which could translate into a greater delay in the time it takes for patients to suffer from the debilitating consequences of MS," said Dr. Mark S. Freedman, Professor of Neurology at the University of Ottawa and investigator of the study. "This is a truly novel finding that has not yet been demonstrated for any other immunomodulatory MS treatment, and underscores the urgent need to treat patients early, rather than waiting for further signs of MS to develop. Physicians and patients should consider these unprecedented findings when making treatment decisions."

"We are delighted that the BENEFIT study continues to deliver groundbreaking results," said Darlene Jody, M.D., Senior Vice President and President, of Bayer Healthcare's Specialized Therapeutics Global Business Unit. "In the past year, Betaseron has received approval around the world f
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
(Date:10/6/2008)...land, October 7 /-,Sosei Gr... and Vectura,Group plc ("Vectura"; LSE: VEC), anno...e efficacy, safety and tolerability of NVA237 pres...ratory Society (ERS) in Berlin,Germany. The new d...ovel,inhaled long-acting muscarinic antagonist (LA...
(Date:10/6/2008)...e-USNewswire/ -- "A return to the use of,chimpanze...hout scientific,justification," according to a pap...aboratory Animals (ATLA). "An Assessment of the Ro...des that vaccine responses in,chimpanzees are not ... of,chimpanzees, critical role and importance in A...
(Date:10/6/2008)...eature children, parents discussing clinical ... Oct. 6 /PRNewswire-USNewswire/ -- From asthma and...en saves lives and improves their,health and well-... of,Health (NIH), "Children and Clinical Studies",...gov ), offers parents and health,care providers an...
(Date:10/6/2008)...udies with Durezol Dosed Prior to Surgery, TAMPA,... Inc., a,privately held ophthalmic-focused biophar...M) (difluprednate ophthalmic emulsion) 0.05% is no...ved by the U.S. Food and,Drug Administration in Ju...dicated for the treatment of inflammation and pain...
Breaking Medicine Technology:NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees 2Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 2Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 3Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5Insects use plant like a telephone 3011 1LifeSync Corporation Agrees to Sublicense Patent Portfolio to Triage Wireless 17527 1WebMD Provides Preliminary First Quarter Results and Updates Financial Guidance for 2008 17524 1WebMD Provides Preliminary First Quarter Results and Updates Financial Guidance for 2008 17524 2WebMD Provides Preliminary First Quarter Results and Updates Financial Guidance for 2008 17524 3WebMD Provides Preliminary First Quarter Results and Updates Financial Guidance for 2008 17524 4WebMD Provides Preliminary First Quarter Results and Updates Financial Guidance for 2008 17524 5WebMD Provides Preliminary First Quarter Results and Updates Financial Guidance for 2008 17524 6WebMD Provides Preliminary First Quarter Results and Updates Financial Guidance for 2008 17524 7WebMD Provides Preliminary First Quarter Results and Updates Financial Guidance for 2008 17524 8WebMD Provides Preliminary First Quarter Results and Updates Financial Guidance for 2008 17524 9Increase in Travel to China Creating New Health and Security Risks 17521 1Increase in Travel to China Creating New Health and Security Risks 17521 2
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...n vegetables like spinach and lettuce, may be resp...new study//. Past studies have shown that a diet ...ssure. But it has been difficult to determine ex...uits and vegetables are responsible for these bloo...
...ng sessions can prompt women to both scale back ri...tion, according to a new study//. Prenatal alcohol...defects and developmental disabilities in the Unit...trategy that could reduce a woman’s risk of an alc...
... has brought to light that taking drugs to ease h...e// the chances of landing with a fractured hip so...sec are drugs used to relieve heartburn.The risk ...rs of age. The researchers have postulated that th...
...ces of dioxin in a U.S. beef consignment to Seoul,...he U.S. officials and the American beef industry a...ally high levels of dioxin, at 6.26 picograms, whi...5-picogram level. USDA spokesman Keith Williams s...
Other Medicine News:Health News:Counseling Helps Young Women Cut Drinking, Improve Contraception Use 2Health News:Counseling Helps Young Women Cut Drinking, Improve Contraception Use 3Health News:Taking Drugs for Heartburn may Cause Fractured Hip 2
Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface.
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface.
Rhoton #12 straight point needle semisharp, titanium.
Rhoton scissors curved tip.
Medicine Products: